Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Women with schizophrenia on atypical antipsychotics are more likely to have polycystic ovarian syndrome (PCOS) than women without schizophrenia.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.